Phibro Animal Health (PAHC) Change in Receivables (2013 - 2026)
Phibro Animal Health (PAHC) posted Change in Receivables of $16.4 million for Q2 2026, up 243.72% on a QoQ basis from $4.8 million in Q1 2026, and down 36.76% year-over-year from $26.0 million in Q2 2025.
Analysis
Phibro Animal Health (PAHC) Change in Receivables (2013 - 2026) Analysis & Trends
Phibro Animal Health has reported Change in Receivables for 14 years, with the latest figure at $16.4 million in Q2 2026.
- On a quarterly basis, Change in Receivables fell 36.76% year-over-year to $16.4 million in Q2 2026; TTM through Jun 2026 was $7.5 million, a 86.43% decrease from a year earlier, with the FY2026 full-year figure at $7.5 million, down 86.43% from the prior year.
- Change in Receivables was $16.4 million for Q2 2026 at Phibro Animal Health, up from $4.8 million in the prior quarter.
- The five-year high for Change in Receivables was $35.0 million in Q4 2024, with the low at -$22.3 million in Q3 2022.
- Average Change in Receivables over 5 years is $5.1 million, with a median of $6.1 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Change in Receivables slumped 411.02% in 2022, then soared 7819.86% in 2024.
- Over 5 years, Change in Receivables stood at $7.5 million in 2022, then slumped by 120.44% to -$1.5 million in 2023, then soared by 2379.41% to $35.0 million in 2024, then sank by 106.67% to -$2.3 million in 2025, then jumped by 803.64% to $16.4 million in 2026.
- The last three Change in Receivables figures came in at $16.4 million (Q2 2026), $4.8 million (Q1 2026), and -$2.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 26.04 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 66.00 Mn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 16.42 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -3,300.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.42 Mn |
| Mar 31, 2026 | 4.78 Mn |
| Dec 31, 2025 | -2.33 Mn |
| Sep 30, 2025 | -11.37 Mn |
| Jun 30, 2025 | 25.96 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | 34.99 Mn |
| Sep 30, 2024 | -9.21 Mn |
| Jun 30, 2024 | 11.72 Mn |
| Mar 31, 2024 | 11.27 Mn |
| Dec 31, 2023 | -1.54 Mn |
| Sep 30, 2023 | -12.78 Mn |
| Jun 30, 2023 | 9.65 Mn |
| Mar 31, 2023 | -146,000.00 |
| Dec 31, 2022 | 7.51 Mn |
| Sep 30, 2022 | -22.35 Mn |
| Jun 30, 2022 | 12.81 Mn |
| Mar 31, 2022 | 12.24 Mn |
| Dec 31, 2021 | 2.95 Mn |
| Sep 30, 2021 | -4.37 Mn |